(Q38008241)

26 August 2017

title

The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: a systematic review (English)

1 reference

positron emission tomography

26 August 2017

1 reference

1 reference

1 reference

1

1 reference

26 August 2017

Maria Picchio

6

0 references

author name string

Elisabetta Giovannini

2

1 reference

26 August 2017

Davide Di Franco

3

1 reference

26 August 2017

Maria Lucia Calcagni

4

1 reference

26 August 2017

Vittoria Rufini

5

1 reference

26 August 2017

Alessandro Giordano

7

1 reference

26 August 2017

publication date

8 May 2012

1 reference

Annals of Nuclear Medicine

26 August 2017

published in

1 reference

26 August 2017

volume

26

1 reference

26 August 2017

issue

6

1 reference

26 August 2017

page(s)

451-461

1 reference

Positron emission tomography imaging of cancer biology: current status and future prospects

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

PET with (18)F-labelled choline-based tracers for tumour imaging: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Could choline PET play a role in malignancies other than prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

The role of PET/computed tomography scan in the management of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Choline and human nutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Tumour phospholipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Oncological diagnosis using (11)C-choline-positron emission tomography in comparison with 2-deoxy-2-[(18)F] fluoro-D-glucose-positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Solitary brain lesions enhancing at MR imaging: evaluation with fluorine 18 fluorocholine PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Misdiagnoses of 11C-choline combined with 18F-FDG PET imaging in brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

C-11 choline versus F-18 fluorodeoxyglucose for imaging meningiomas: an initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Metabolic assessment of monofocal acute inflammatory demyelination using MR spectroscopy and (11)C-methionine-, (11)C-choline-, and (18)F-fluorodeoxyglucose-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Comparison of C-11 methionine and C-11 choline for PET imaging of brain metastases: a prospective pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Comparison of MRI, F-18 FDG, and 11C-choline PET/CT for their potentials in differentiating brain tumor recurrence from brain tumor necrosis following radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

F-18 choline PET does not detect increased metabolism in F-18 fluoroethyltyrosine-negative low-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Diagnosis of tumor in the nasal cavity and paranasal sinuses with [11C]choline PET: comparative study with 2-[18F]fluoro-2-deoxy-D-glucose (FDG) PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

18F-FDG versus 11C-choline PET/CT for the imaging of advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy: the time period during which PET/CT can reliably detect non-recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Comparison of 18F-FDG and 11C-choline PET/CT for detecting recurrences in patients with nonsquamous cell head and neck malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Positron emission tomography of esophageal carcinoma using (11)C-choline and (18)F-fluorodeoxyglucose: a novel method of preoperative lymph node staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Carbon-11 choline or FDG-PET for staging of oesophageal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Differentiation of hepatocellular adenoma and focal nodular hyperplasia using 18F-fluorocholine PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Measurement of myocardial beta-adrenoceptor density in clinical studies: a role for positron emission tomography?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Contribution of 11C-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Role of carbon-11 choline PET/CT in the management of uterine carcinoma: initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

[11C]choline positron emission tomography in estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Reproducibility of [11C]choline-positron emission tomography and effect of trastuzumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Biological basis of [¹¹C]choline-positron emission tomography in patients with breast cancer: comparison with [¹⁸F]fluorothymidine positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

11C-choline PET for the detection of bone and soft tissue tumours in comparison with FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

Carbon-11 choline positron emission tomography in musculoskeletal tumors: comparison with fluorine-18 fluorodeoxyglucose positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

The rising PET: the increasing use of choline PET/CT in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0602-7

10.1007/S12149-012-0602-7

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

1013210120

0 references

1 reference